Youhua Xu

3.9k total citations · 1 hit paper
131 papers, 3.0k citations indexed

About

Youhua Xu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Youhua Xu has authored 131 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 22 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Neurology. Recurrent topics in Youhua Xu's work include Advanced Glycation End Products research (19 papers), Traditional Chinese Medicine Analysis (14 papers) and Chronic Kidney Disease and Diabetes (12 papers). Youhua Xu is often cited by papers focused on Advanced Glycation End Products research (19 papers), Traditional Chinese Medicine Analysis (14 papers) and Chronic Kidney Disease and Diabetes (12 papers). Youhua Xu collaborates with scholars based in China, Macao and Hong Kong. Youhua Xu's co-authors include Wei Huang, Yong Xu, Quan Zhu, Yonghua Zhao, Chenlin Gao, Jianfeng Xiong, Junling Gu, Dingkun Gui, Bowen Liu and Tingting Zhao and has published in prestigious journals such as Biomaterials, Diabetes and Journal of Agricultural and Food Chemistry.

In The Last Decade

Youhua Xu

122 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway

2024 56 citations Ruixue Dong, Dingkun Gui et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Youhua Xu China	30	1.5k	525	416	301	282	131	3.0k
Rajarajan A. Thandavarayan United States	38	1.7k 1.2×	482 0.9×	447 1.1×	367 1.2×	492 1.7×	136	4.2k
Xian Zhang China	33	1.2k 0.8×	691 1.3×	436 1.0×	518 1.7×	344 1.2×	146	3.7k
Eun Kyeong Lee South Korea	29	1.1k 0.8×	519 1.0×	181 0.4×	366 1.2×	289 1.0×	78	2.8k
Kunka Mohanram Ramkumar India	37	1.5k 1.0×	324 0.6×	832 2.0×	391 1.3×	210 0.7×	137	3.7k
Mohanraj Rajesh United States	43	1.8k 1.3×	693 1.3×	936 2.3×	483 1.6×	385 1.4×	84	6.1k
Yonggang Wang China	38	2.1k 1.5×	358 0.7×	305 0.7×	297 1.0×	400 1.4×	192	4.6k
Chi Wai Lau Hong Kong	34	1.3k 0.9×	828 1.6×	554 1.3×	373 1.2×	388 1.4×	82	3.6k
Steven J. Forrester United States	16	1.4k 0.9×	423 0.8×	321 0.8×	285 0.9×	419 1.5×	22	3.4k
Nurten Aksoy Türkiye	33	601 0.4×	335 0.6×	351 0.8×	224 0.7×	214 0.8×	159	3.5k

Countries citing papers authored by Youhua Xu

Since Specialization

Citations

This map shows the geographic impact of Youhua Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youhua Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youhua Xu more than expected).

Fields of papers citing papers by Youhua Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youhua Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youhua Xu. The network helps show where Youhua Xu may publish in the future.

Co-authorship network of co-authors of Youhua Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Youhua Xu. A scholar is included among the top collaborators of Youhua Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youhua Xu. Youhua Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Weiming, et al.. (2025). Cigarette smoking extract induces mitochondrial dysfunction and apoptosis in HUVECs via the Sirt1-SHH axis. Human & Experimental Toxicology. 44. 3550350491–3550350491. 1 indexed citations

Xu, Youhua, et al.. (2025). Potential and Mechanism of Nobiletin in Diabetes Mellitus and Associated Complications. Pharmaceuticals. 18(10). 1528–1528.

Zhang, Wenqian, et al.. (2025). ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC). Journal of Cancer. 16(5). 1736–1746. 4 indexed citations

Wang, Wei‐Ming, et al.. (2024). Mulberroside A attenuates cigarette smoke-induced atherosclerosis in ApoE−/− mice via the Sirt1-HIF-1α axis. Cellular Signalling. 124. 111400–111400. 2 indexed citations

Li, Jing, Qi Huang, Jialing Sun, et al.. (2024). Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes. Journal of Ethnopharmacology. 333. 118400–118400. 8 indexed citations

Zhou, Jiaqi, Weiyi Xia, Jiajia Chen, et al.. (2024). Propofol and salvianolic acid A synergistically attenuated cardiac ischemia–reperfusion injury in diabetic mice via modulating the CD36/AMPK pathway. Burns & Trauma. 12. tkad055–tkad055. 12 indexed citations

Liu, Pei, Wanli Liang, Rui‐Ting Huang, et al.. (2024). Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine. Frontiers in Pharmacology. 15. 1399598–1399598. 2 indexed citations

Xu, Youhua, et al.. (2023). Research on Agricultural Product Traceability System Based on Blockchain. 746–752.

Yao, Ji, Huanyuan Shan, Ran Li, et al.. (2023). CSST WL preparation I: forecast the impact from non-Gaussian covariances and requirements on systematics control. Monthly Notices of the Royal Astronomical Society. 527(3). 5206–5218. 9 indexed citations

10.

Li, Yaqin, Guoxin Hu, Furong Huang, et al.. (2023). MAT1A Suppression by the CTBP1/HDAC1/HDAC2 Transcriptional Complex Induces Immune Escape and Reduces Ferroptosis in Hepatocellular Carcinoma. Laboratory Investigation. 103(8). 100180–100180. 12 indexed citations

11.

Zhao, Tingting, Junling Gu, Zhe Wang, et al.. (2022). Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axis. Chinese Medicine. 17(1). 22–22. 36 indexed citations

12.

Gu, Junling, Kang Geng, Man Guo, et al.. (2022). Targeting Pyroptosis: New Insights into the Treatment of Diabetic Microvascular Complications. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 6 indexed citations

13.

Gui, Dingkun, et al.. (2022). Efficacy and Safety of Salvia miltiorrhiza for Treating Chronic Kidney Diseases: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–18. 7 indexed citations

14.

Wang, Weiming, Tingting Zhao, Kang Geng, et al.. (2021). Smoking and the Pathophysiology of Peripheral Artery Disease. Frontiers in Cardiovascular Medicine. 8. 704106–704106. 48 indexed citations

15.

Xu, Yinyan, et al.. (2021). Mulberroside A from Cortex Mori Enhanced Gut Integrity in Diabetes. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 9 indexed citations

16.

Wang, Zhe, Tingting Zhao, Ruixue Dong, et al.. (2021). Total flavonoids of Astragalus Ameliorated Bile Acid Metabolism Dysfunction in Diabetes Mellitus. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 15 indexed citations

17.

Huang, Wei, Chenlin Gao, Luping Zhou, et al.. (2020). Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling. Oxidative Medicine and Cellular Longevity. 2020. 1–21. 144 indexed citations

18.

Gao, Chenlin, Jiao Chen, Fang Fan, et al.. (2019). RIPK2-Mediated Autophagy and Negatively Regulated ROS-NLRP3 Inflammasome Signaling in GMCs Stimulated with High Glucose. Mediators of Inflammation. 2019. 1–13. 25 indexed citations

19.

Zhai, Ruonan, Guihua Jian, Ling Xie, et al.. (2019). Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research. 2019. 1–14. 23 indexed citations

20.

Li, Yanhui, Wei Huang, Youhua Xu, et al.. (2017). CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-κB Inflammatory Signaling in Mesangial Cells. BioMed Research International. 2017. 1–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact